Oculis Holding AG Warrants (OCSAW)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

The chart shows the growth of an initial investment of $10,000 in Oculis Holding AG Warrants, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.

Oculis Holding AG Warrants (OCSAW) has returned 51.87% so far this year and 72.27% over the past 12 months.

Based on dividend-adjusted daily data since Mar 3, 2023, OCSAW's average daily return is +0.74%, while the average monthly return is +15.59%. At this rate, your investment would double in approximately 0.4 years.

Historically, 57% of months were positive and 43% were negative. The best month was Oct 2024 with a return of +161.9%, while the worst month was Oct 2023 at -33.1%. The longest winning streak lasted 4 consecutive months, and the longest losing streak was 3 months.

On a daily basis, OCSAW closed higher 28% of trading days. The best single day was Jan 4, 2024 with a return of +60.5%, while the worst single day was Jan 3, 2024 at -49.3%.

Oculis Holding AG Warrants has an annualized alpha of 454.00%, beta of 0.83, and R² of 0.01 versus S&P 500 Index. Calculated based on daily prices since March 06, 2023.

• This stock captured 676.41% of S&P 500 Index gains and tended to rise during its downturns (downside capture of -183.21%) — a profile typical of hedging or uncorrelated assets.
• R² of 0.01 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

OCSAW ranks 70 for risk / return — better than 70% of stocks on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.

The table below present risk-adjusted performance metrics for Oculis Holding AG Warrants (OCSAW) and compare them to a chosen benchmark (S&P 500 Index).

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Oculis Holding AG Warrants. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Oculis Holding AG Warrants was 72.36%, occurring on Jan 3, 2024. Recovery took 36 trading sessions.

The current Oculis Holding AG Warrants drawdown is 29.73%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Oculis Holding AG Warrants over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Oculis Holding AG Warrants is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.